Position in TRVI
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$4,117,043
-$203,609 QoQ
Shares Held
345,100
0.0% QoQ
Ownership
0.243%
of shares outstanding
% of Portfolio
0.55%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2022
14 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in TRVI Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Opaleye Management Inc. holds $427,835,777 across 44 Biotechnology names. TRVI ranks #29 (1.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | SLGL |
Sol-Gel Technologies Ltd.
|
500,000 | $39,610,000 | |
| 2 | APGE |
Apogee Therapeutics, Inc.
|
390,000 | $32,826,300 | |
| 3 | IRON |
Disc Medicine, Inc.
|
421,000 | $26,918,740 | |
| 4 | URGN |
UroGen Pharma Ltd.
|
1,430,000 | $25,711,400 | |
| 5 | CBIO |
Crescent Biopharma, Inc.
|
1,312,615 | $24,112,737 | |
| 6 | STOK |
Stoke Therapeutics, Inc.
|
700,000 | $22,792,000 | |
| 7 | RZLT |
Rezolute, Inc.
|
6,300,000 | $19,215,000 | |
| 8 | MGTX |
MeiraGTx Holdings plc
|
2,123,259 | $18,387,422 |
All Filings in TRVI
Export CSV
14 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $4,117,043 | 345,100 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $4,320,652 | 345,100 | Shares | Sole | 2026-04-13 | |
| 2025-09-30 | $3,568,500 | 390,000 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $2,133,300 | 390,000 | Shares | Sole | 2025-08-15 | |
| 2025-03-31 | $5,000,550 | 795,000 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $9,548,100 | 2,317,500 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $8,577,086 | 2,567,990 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $7,882,100 | 2,645,000 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $9,125,250 | 2,645,000 | Shares | Sole | 2024-05-29 | |
| 2023-12-31 | $3,396,900 | 2,535,000 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $3,718,862 | 1,705,900 | Shares | Sole | 2023-11-15 | |
| 2023-06-30 | $4,066,585 | 1,701,500 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $1,546,230 | 835,800 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $936,050 | 485,000 | Shares | Sole | 2023-02-10 | |
| No filing history on record for this holder in this stock. | ||||||